<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11860375</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.707</article-id><article-id pub-id-type="other">EPP0598</article-id><article-id pub-id-type="pii">S0924933824007077</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Presentation</subject></subj-group></article-categories><title-group><article-title>Subgroups of patients with late onset schizophrenia-like psychoses revealed by the analysis of glutathione-dependent enzymes and inflammation markers</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Prokhorova</surname><given-names>T.</given-names></name><xref rid="aff1681" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor0568" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Boksha</surname><given-names>I.</given-names></name><xref rid="aff1681" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Androsova</surname><given-names>L.</given-names></name><xref rid="aff1681" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Tereshkina</surname><given-names>E.</given-names></name><xref rid="aff1681" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Pochueva</surname><given-names>V.</given-names></name><xref rid="aff1681" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Savushkina</surname><given-names>O.</given-names></name><xref rid="aff1681" ref-type="aff">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="aff1681"><sup>1</sup><institution>FSBSI &#x0201c;MENTAL HEALTH RESEARCH CENTRE&#x0201d;</institution>, <city>Moscow</city>, <country>
Russian Federation</country></aff><author-notes><corresp id="cor0568"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="682">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S342</fpage><lpage>S343</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0924933824007077a.pdf"/><abstract><sec id="sec3414"><title>Introduction</title><p>While chronic inflammation and enhanced imbalance of pro- and antioxidant, including glutathione-dependent, systems contribute substantially to pathogenesis of mental disorders in old age, extent of oxidative stress and degree of inflammatory processes severity are varying among patients with late onset schizophrenia.</p></sec><sec id="sec3415"><title>Objectives</title><p>Revealing various phenotypes in patients with late onset schizophrenia basing on measurement of activity levels for blood glutathione-dependent enzymes and inflammation markers and analysis of their links with clinical features of the patients.</p></sec><sec id="sec3416"><title>Methods</title><p>Of 59 studied women patients 34 were with late onset (after 40 years) and 25 with very late onset (after 60 years) schizophrenia or schizophrenia-like psychoses (F20; F22.8; F25; F23; F06.2 by ICD-10). 34 mentally healthy women elder than 50 years comprised controls. Glutathione reductase (GR), glutathione-S-transferase (GST), neutrophil elastase (NE), and &#x003b1;1-roteinase inhibitor (&#x003b1;1-PI) activities were measured in blood. PANSS, CDSS and CGI-S were used to assess the severity of psychotic symptoms, depression and treatment effectiveness.</p></sec><sec id="sec3417"><title>Results</title><p>In the whole group of patients, GR was lower (<italic toggle="yes">p</italic>&#x0003c;0.05), and &#x003b1;1-PI was higher (<italic toggle="yes">p</italic>&#x0003c;0.0001) than in control group. Clustering the patients by their biochemical and immunological signs revealed two clusters (C1, n=34, and C2, n=25) significantly differing by GST (<italic toggle="yes">p</italic>&#x0003c;0.0001), NE (<italic toggle="yes">p</italic>&#x0003c;0.0001), and &#x003b1;1-PI (<italic toggle="yes">p</italic>&#x0003c;0.001) activities. As compared with controls, GST and &#x003b1;1-PI were higher (<italic toggle="yes">p</italic>&#x0003c;0.05 and <italic toggle="yes">p</italic>&#x0003c;0.0001), and NE was lower (<italic toggle="yes">p</italic>&#x0003c;0.05) in C1. As compared with controls, GR activity was lower (<italic toggle="yes">p</italic>&#x0003c;0.05), NE activity was higher (<italic toggle="yes">p</italic>&#x0003c;0.001), and &#x003b1;1-PI activity was much higher (<italic toggle="yes">p</italic>&#x0003c;0.001) in C2. Patients of C1 and C2 did not differ in age, diagnosis, severity of the disease, but differed in clinical features of the course of the disease: significantly more patients with very late onset schizophrenia (76%) were met in C1 (&#x003c7;2=13.41, <italic toggle="yes">p</italic>&#x0003c;0.001). Also, different clinical-biological correlations were found in these clusters. Particularly, negative correlations of baseline NE activity with PANSS general psychopathology subscale scores (R=-0.39, <italic toggle="yes">p</italic>&#x0003c;0.05) and with total PANSS scores (R=-0.39, <italic toggle="yes">p</italic>&#x0003c;0.05) were found in C1. Positive correlation of GST activity with PANSS positive subscale score was found in C2 (R=0.43, <italic toggle="yes">p</italic>&#x0003c;0.05).</p></sec><sec id="sec3418"><title>Conclusions</title><p>The revealed clusters differ in the extent of the glutathione antioxidant system impairment and in levels of the immune response markers. The revealing of the patient subgroups on the basis of biological markers reflecting impairments in metabolic and immune systems can represent interest in the search for individual treatment approaches.</p></sec><sec id="sec3419"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="2"/></counts></article-meta></front></article>